Phase II trial of combination thalidomide (thal) plus temozolomide (TMZ [TT]), in patients with metastatic malignant melanoma (MMM): Southwest Oncology Group S0508

Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ

History

Strength training, wal

Subgroup analysis of e

Nuclease modulates bio

Pearls & Oy-sters: Bow

Phase II trial of comb

See All (8) pages

Announcement

You can now add alternative names! Click here to add other names that you've published under.

Phase II trial of combination thalidomide (thal) plus temozolomide (TMZ [TT]), in patients with metastatic malignant melanoma (MMM): Southwest Oncology Group S0508

Clark J, Moon J, Hutchins LF, Sosman JA, Kast WM, Da Silva D, Liu PY, Thompson JA, Sondak VK. Phase II trial of combination thalidomide (thal) plus temozolomide (TMZ [TT]), in patients with metastatic malignant melanoma (MMM): Southwest Oncology Group S0508. J Clin Oncol 26 (May 20 suppl). 2008.